Back to Database
Status published
High
CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated...
Vulnerability Description
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
THREAT MONITOR
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2015-3965
Credits & Attribution
No credits recorded in the NVD database.
More from Hospira
View All →CVE-2015-3956
Hospira Plum A+ Infusion System version 13.4 and prior, Plum...
Critical
9.8
CVE-2015-3954
Hospira Plum A+ Infusion System version 13.4 and prior, Plum...
Critical
9.8
CVE-2015-3953
Hard-coded accounts may be used to access Hospira Plum A+...
Critical
9.8
CVE-2015-3952
Wireless keys are stored in plain text on Hospira Plum...
High
7.5
CVE-2015-1012
Wireless keys are stored in plain text on version 5...
High
7.5
Affected Vendor
Hospira
View all reports →Affected Software
Symbiq Infusion System
Vulnerable Versions:
3.13 and earlier
Timeline
Official Publish:
March 23rd, 2019
Last Modified:
August 6th, 2024
Added to House:
July 19th, 2026
CVSS Vectors
V3:
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weaknesses (CWE)
No CWE data available
MITRE ATT&CK TTPs
No associated TTPs found for this vulnerability.